Nov. 30 at 9:31 PM
$PRPH $SMX $BYND $PW $ABVE
PRPH:
$50M Settlement + AI-Genomics Catalysts Converging
Dec 1st after-hours investor webinar
• ProPhase Labs (NASDAQ: PRPH) wholly owns Nebula Genomics (acquired 2021), with one of the world’s largest, most diverse whole-genome sequencing (WGS) databases.
• 2025 Project ZenQ-AI: Trains AI models on Nebula data for drug discovery, cancer diagnostics (BE-Smart esophageal test), and personalized medicine.
• DNA Complete® (launched Nov): DTC 100% WGS + AI reports.
• DNA Expand™: Subscription upgrading 23andMe-style data with AI insights.
• Partnership with G42 Healthcare (Abu Dhabi) to speed sequencing, cut costs, and expand the dataset.
Core moat: consented, high-quality WGS data ideal for AI training — a scarce, valuable asset.
Near-term catalysts:
$50M net from first Crown settlement (COVID receivables), BE-Smart commercialization, Nebula profitability, ongoing M&A talks, and ZenQ-AI updates at the Dec 1, 2025 webinar.
